Register entry
Shandong Anhong Pharmaceutical Co., Ltd.
- Registered sites
- 1
- Drug products
- 8
- Live patents
- 0
- Countries
- 1
- Base
- China
Authorisation
Registered operations
What the FDA has registered these sites to do. This is the regulatory record, not a marketing claim.
Analytical testingActive ingredient (API) manufactureLabellingFinished drug manufacturePackaging
Sites
Facilities
1| Site | Location | Operations | FEI |
|---|---|---|---|
| Shandong Anhong Pharmaceutical Co., Ltd. | DezhouChina | Analytical testing, Active ingredient (API) manufacture, Labelling, Finished drug manufacture, Packaging | 3003877289 |
Catalogue
Marketed products
8Showing 8 of 8.
| Brand | Generic name | Form | Category |
|---|---|---|---|
| - | Etoposide | POWDER | BULK INGREDIENT |
| - | Exemestane | POWDER | BULK INGREDIENT |
| - | Meropenem with sodium carbonate | POWDER | BULK INGREDIENT |
| - | Olaparib | POWDER | BULK INGREDIENT |
| - | Palbociclib | POWDER | BULK INGREDIENT |
| - | Pemetrexed Disodium | POWDER | BULK INGREDIENT |
| - | Ropivacaine Hydrochloride | POWDER | BULK INGREDIENT |
| - | Terbinafine Hydrochloride | POWDER | BULK INGREDIENT |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.